Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Generic drugs refer to drugs that have the same chemical composition as existing branded drugs. These drugs are cheap and comparable to brand-name drugs in terms of dosage, strength, route of administration, quality, performance and application. Generic drugs are subject to national government regulations, rather than being associated with specific companies.
From 2019 to 2026, the global generic drug market will grow from USD 384.6 billion in 2019 to USD 683.2 billion in 2026, and will grow at a CAGR of 8.55% during the forecast period.
The main factors contributing to the growth of the generic drug market include the increase in the prevalence of chronic diseases, diabetes and cardiovascular diseases, the growth of the elderly population, the increase in health care expenditures, the strong demand for generic drugs and a large number of expired patent and trademark drugs. Many positive measures taken by governments to promote the use of generic drugs are expected to provide impetus to market growth. Some regulatory agencies are conducting rigorous reviews to ensure that the best standards are met in the production of these drugs.
Generic Drugs market report explains the definition, types, applications, major countries, and major players of the Generic Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Zydus Cadila
Aspen
Fresenius Kabi
Cipla
Aurobindo
Pfizer (Hospira)
Teva
Sanofi
Stada Arzneimittel
Nichi-Iko Pharmaceutical
Krka Group
Sun Pharmaceutical
Lupin
Mylan
Valeant
Apotex
Hikma
Novartis - Sandoz
ENDO (Par Pharmaceutical)
By Type:
Oral
Injectables
Dermal/Topical
Inhalers
By End-User:
Hospital Pharmacies
Retail Pharmacies
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Generic Drugs Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Generic Drugs Outlook to 2028- Original Forecasts
-
2.2 Generic Drugs Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Generic Drugs Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Generic Drugs Market- Recent Developments
-
6.1 Generic Drugs Market News and Developments
-
6.2 Generic Drugs Market Deals Landscape
7 Generic Drugs Raw Materials and Cost Structure Analysis
-
7.1 Generic Drugs Key Raw Materials
-
7.2 Generic Drugs Price Trend of Key Raw Materials
-
7.3 Generic Drugs Key Suppliers of Raw Materials
-
7.4 Generic Drugs Market Concentration Rate of Raw Materials
-
7.5 Generic Drugs Cost Structure Analysis
-
7.5.1 Generic Drugs Raw Materials Analysis
-
7.5.2 Generic Drugs Labor Cost Analysis
-
7.5.3 Generic Drugs Manufacturing Expenses Analysis
8 Global Generic Drugs Import and Export Analysis (Top 10 Countries)
-
8.1 Global Generic Drugs Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Generic Drugs Export by Region (Top 10 Countries) (2017-2028)
9 Global Generic Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Generic Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Injectables Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Dermal/Topical Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Inhalers Consumption and Growth Rate (2017-2022)
-
9.2 Global Generic Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Generic Drugs Market Analysis and Outlook till 2022
-
10.1 Global Generic Drugs Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Generic Drugs Consumption (2017-2022)
-
10.2.2 Canada Generic Drugs Consumption (2017-2022)
-
10.2.3 Mexico Generic Drugs Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Generic Drugs Consumption (2017-2022)
-
10.3.2 UK Generic Drugs Consumption (2017-2022)
-
10.3.3 Spain Generic Drugs Consumption (2017-2022)
-
10.3.4 Belgium Generic Drugs Consumption (2017-2022)
-
10.3.5 France Generic Drugs Consumption (2017-2022)
-
10.3.6 Italy Generic Drugs Consumption (2017-2022)
-
10.3.7 Denmark Generic Drugs Consumption (2017-2022)
-
10.3.8 Finland Generic Drugs Consumption (2017-2022)
-
10.3.9 Norway Generic Drugs Consumption (2017-2022)
-
10.3.10 Sweden Generic Drugs Consumption (2017-2022)
-
10.3.11 Poland Generic Drugs Consumption (2017-2022)
-
10.3.12 Russia Generic Drugs Consumption (2017-2022)
-
10.3.13 Turkey Generic Drugs Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Generic Drugs Consumption (2017-2022)
-
10.4.2 Japan Generic Drugs Consumption (2017-2022)
-
10.4.3 India Generic Drugs Consumption (2017-2022)
-
10.4.4 South Korea Generic Drugs Consumption (2017-2022)
-
10.4.5 Pakistan Generic Drugs Consumption (2017-2022)
-
10.4.6 Bangladesh Generic Drugs Consumption (2017-2022)
-
10.4.7 Indonesia Generic Drugs Consumption (2017-2022)
-
10.4.8 Thailand Generic Drugs Consumption (2017-2022)
-
10.4.9 Singapore Generic Drugs Consumption (2017-2022)
-
10.4.10 Malaysia Generic Drugs Consumption (2017-2022)
-
10.4.11 Philippines Generic Drugs Consumption (2017-2022)
-
10.4.12 Vietnam Generic Drugs Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Generic Drugs Consumption (2017-2022)
-
10.5.2 Colombia Generic Drugs Consumption (2017-2022)
-
10.5.3 Chile Generic Drugs Consumption (2017-2022)
-
10.5.4 Argentina Generic Drugs Consumption (2017-2022)
-
10.5.5 Venezuela Generic Drugs Consumption (2017-2022)
-
10.5.6 Peru Generic Drugs Consumption (2017-2022)
-
10.5.7 Puerto Rico Generic Drugs Consumption (2017-2022)
-
10.5.8 Ecuador Generic Drugs Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Generic Drugs Consumption (2017-2022)
-
10.6.2 Kuwait Generic Drugs Consumption (2017-2022)
-
10.6.3 Oman Generic Drugs Consumption (2017-2022)
-
10.6.4 Qatar Generic Drugs Consumption (2017-2022)
-
10.6.5 Saudi Arabia Generic Drugs Consumption (2017-2022)
-
10.6.6 United Arab Emirates Generic Drugs Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Generic Drugs Consumption (2017-2022)
-
10.7.2 South Africa Generic Drugs Consumption (2017-2022)
-
10.7.3 Egypt Generic Drugs Consumption (2017-2022)
-
10.7.4 Algeria Generic Drugs Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Generic Drugs Consumption (2017-2022)
-
10.8.2 New Zealand Generic Drugs Consumption (2017-2022)
11 Global Generic Drugs Competitive Analysis
-
11.1 Zydus Cadila
-
11.1.1 Zydus Cadila Company Details
-
11.1.2 Zydus Cadila Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Zydus Cadila Generic Drugs Main Business and Markets Served
-
11.1.4 Zydus Cadila Generic Drugs Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Aspen
-
11.2.1 Aspen Company Details
-
11.2.2 Aspen Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Aspen Generic Drugs Main Business and Markets Served
-
11.2.4 Aspen Generic Drugs Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Fresenius Kabi
-
11.3.1 Fresenius Kabi Company Details
-
11.3.2 Fresenius Kabi Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Fresenius Kabi Generic Drugs Main Business and Markets Served
-
11.3.4 Fresenius Kabi Generic Drugs Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Cipla
-
11.4.1 Cipla Company Details
-
11.4.2 Cipla Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Cipla Generic Drugs Main Business and Markets Served
-
11.4.4 Cipla Generic Drugs Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Aurobindo
-
11.5.1 Aurobindo Company Details
-
11.5.2 Aurobindo Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Aurobindo Generic Drugs Main Business and Markets Served
-
11.5.4 Aurobindo Generic Drugs Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Pfizer (Hospira)
-
11.6.1 Pfizer (Hospira) Company Details
-
11.6.2 Pfizer (Hospira) Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Pfizer (Hospira) Generic Drugs Main Business and Markets Served
-
11.6.4 Pfizer (Hospira) Generic Drugs Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Teva
-
11.7.1 Teva Company Details
-
11.7.2 Teva Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Teva Generic Drugs Main Business and Markets Served
-
11.7.4 Teva Generic Drugs Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Sanofi
-
11.8.1 Sanofi Company Details
-
11.8.2 Sanofi Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Sanofi Generic Drugs Main Business and Markets Served
-
11.8.4 Sanofi Generic Drugs Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Stada Arzneimittel
-
11.9.1 Stada Arzneimittel Company Details
-
11.9.2 Stada Arzneimittel Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Stada Arzneimittel Generic Drugs Main Business and Markets Served
-
11.9.4 Stada Arzneimittel Generic Drugs Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Nichi-Iko Pharmaceutical
-
11.10.1 Nichi-Iko Pharmaceutical Company Details
-
11.10.2 Nichi-Iko Pharmaceutical Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Nichi-Iko Pharmaceutical Generic Drugs Main Business and Markets Served
-
11.10.4 Nichi-Iko Pharmaceutical Generic Drugs Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Krka Group
-
11.11.1 Krka Group Company Details
-
11.11.2 Krka Group Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Krka Group Generic Drugs Main Business and Markets Served
-
11.11.4 Krka Group Generic Drugs Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Sun Pharmaceutical
-
11.12.1 Sun Pharmaceutical Company Details
-
11.12.2 Sun Pharmaceutical Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Sun Pharmaceutical Generic Drugs Main Business and Markets Served
-
11.12.4 Sun Pharmaceutical Generic Drugs Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Lupin
-
11.13.1 Lupin Company Details
-
11.13.2 Lupin Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Lupin Generic Drugs Main Business and Markets Served
-
11.13.4 Lupin Generic Drugs Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Mylan
-
11.14.1 Mylan Company Details
-
11.14.2 Mylan Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Mylan Generic Drugs Main Business and Markets Served
-
11.14.4 Mylan Generic Drugs Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Valeant
-
11.15.1 Valeant Company Details
-
11.15.2 Valeant Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Valeant Generic Drugs Main Business and Markets Served
-
11.15.4 Valeant Generic Drugs Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Apotex
-
11.16.1 Apotex Company Details
-
11.16.2 Apotex Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Apotex Generic Drugs Main Business and Markets Served
-
11.16.4 Apotex Generic Drugs Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Hikma
-
11.17.1 Hikma Company Details
-
11.17.2 Hikma Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Hikma Generic Drugs Main Business and Markets Served
-
11.17.4 Hikma Generic Drugs Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Novartis - Sandoz
-
11.18.1 Novartis - Sandoz Company Details
-
11.18.2 Novartis - Sandoz Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Novartis - Sandoz Generic Drugs Main Business and Markets Served
-
11.18.4 Novartis - Sandoz Generic Drugs Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 ENDO (Par Pharmaceutical)
-
11.19.1 ENDO (Par Pharmaceutical) Company Details
-
11.19.2 ENDO (Par Pharmaceutical) Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 ENDO (Par Pharmaceutical) Generic Drugs Main Business and Markets Served
-
11.19.4 ENDO (Par Pharmaceutical) Generic Drugs Product Portfolio
-
11.19.5 Recent Research and Development Strategies
12 Global Generic Drugs Market Outlook by Types and Applications to 2028
-
12.1 Global Generic Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Injectables Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Dermal/Topical Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Inhalers Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Generic Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Generic Drugs Market Analysis and Outlook to 2028
-
13.1 Global Generic Drugs Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Generic Drugs Consumption Forecast (2022-2028)
-
13.2.2 Canada Generic Drugs Consumption Forecast (2022-2028)
-
13.2.3 Mexico Generic Drugs Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Generic Drugs Consumption Forecast (2022-2028)
-
13.3.2 UK Generic Drugs Consumption Forecast (2022-2028)
-
13.3.3 Spain Generic Drugs Consumption Forecast (2022-2028)
-
13.3.4 Belgium Generic Drugs Consumption Forecast (2022-2028)
-
13.3.5 France Generic Drugs Consumption Forecast (2022-2028)
-
13.3.6 Italy Generic Drugs Consumption Forecast (2022-2028)
-
13.3.7 Denmark Generic Drugs Consumption Forecast (2022-2028)
-
13.3.8 Finland Generic Drugs Consumption Forecast (2022-2028)
-
13.3.9 Norway Generic Drugs Consumption Forecast (2022-2028)
-
13.3.10 Sweden Generic Drugs Consumption Forecast (2022-2028)
-
13.3.11 Poland Generic Drugs Consumption Forecast (2022-2028)
-
13.3.12 Russia Generic Drugs Consumption Forecast (2022-2028)
-
13.3.13 Turkey Generic Drugs Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Generic Drugs Consumption Forecast (2022-2028)
-
13.4.2 Japan Generic Drugs Consumption Forecast (2022-2028)
-
13.4.3 India Generic Drugs Consumption Forecast (2022-2028)
-
13.4.4 South Korea Generic Drugs Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Generic Drugs Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Generic Drugs Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Generic Drugs Consumption Forecast (2022-2028)
-
13.4.8 Thailand Generic Drugs Consumption Forecast (2022-2028)
-
13.4.9 Singapore Generic Drugs Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Generic Drugs Consumption Forecast (2022-2028)
-
13.4.11 Philippines Generic Drugs Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Generic Drugs Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Generic Drugs Consumption Forecast (2022-2028)
-
13.5.2 Colombia Generic Drugs Consumption Forecast (2022-2028)
-
13.5.3 Chile Generic Drugs Consumption Forecast (2022-2028)
-
13.5.4 Argentina Generic Drugs Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Generic Drugs Consumption Forecast (2022-2028)
-
13.5.6 Peru Generic Drugs Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Generic Drugs Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Generic Drugs Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Generic Drugs Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Generic Drugs Consumption Forecast (2022-2028)
-
13.6.3 Oman Generic Drugs Consumption Forecast (2022-2028)
-
13.6.4 Qatar Generic Drugs Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Generic Drugs Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Generic Drugs Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Generic Drugs Consumption Forecast (2022-2028)
-
13.7.2 South Africa Generic Drugs Consumption Forecast (2022-2028)
-
13.7.3 Egypt Generic Drugs Consumption Forecast (2022-2028)
-
13.7.4 Algeria Generic Drugs Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Generic Drugs Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Generic Drugs Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Generic Drugs
-
Figure of Generic Drugs Picture
-
Table Global Generic Drugs Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Generic Drugs Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Injectables Consumption and Growth Rate (2017-2022)
-
Figure Global Dermal/Topical Consumption and Growth Rate (2017-2022)
-
Figure Global Inhalers Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Generic Drugs Consumption by Country (2017-2022)
-
Table North America Generic Drugs Consumption by Country (2017-2022)
-
Figure United States Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Canada Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Mexico Generic Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Generic Drugs Consumption by Country (2017-2022)
-
Figure Germany Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure UK Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Spain Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Belgium Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure France Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Italy Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Denmark Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Finland Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Norway Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Sweden Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Poland Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Russia Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Turkey Generic Drugs Consumption and Growth Rate (2017-2022)
-
Table APAC Generic Drugs Consumption by Country (2017-2022)
-
Figure China Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Thailand Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Singapore Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Philippines Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Generic Drugs Consumption and Growth Rate (2017-2022)
-
Table South America Generic Drugs Consumption by Country (2017-2022)
-
Figure Brazil Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Colombia Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Chile Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Argentina Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Peru Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Generic Drugs Consumption and Growth Rate (2017-2022)
-
Table GCC Generic Drugs Consumption by Country (2017-2022)
-
Figure Bahrain Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Oman Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Qatar Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Generic Drugs Consumption and Growth Rate (2017-2022)
-
Table Africa Generic Drugs Consumption by Country (2017-2022)
-
Figure Nigeria Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Africa Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Egypt Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Algeria Generic Drugs Consumption and Growth Rate (2017-2022)
-
Table Oceania Generic Drugs Consumption by Country (2017-2022)
-
Figure Australia Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Generic Drugs Consumption and Growth Rate (2017-2022)
-
Table Zydus Cadila Company Details
-
Table Zydus Cadila Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zydus Cadila Generic Drugs Main Business and Markets Served
-
Table Zydus Cadila Generic Drugs Product Portfolio
-
Table Aspen Company Details
-
Table Aspen Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aspen Generic Drugs Main Business and Markets Served
-
Table Aspen Generic Drugs Product Portfolio
-
Table Fresenius Kabi Company Details
-
Table Fresenius Kabi Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fresenius Kabi Generic Drugs Main Business and Markets Served
-
Table Fresenius Kabi Generic Drugs Product Portfolio
-
Table Cipla Company Details
-
Table Cipla Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Generic Drugs Main Business and Markets Served
-
Table Cipla Generic Drugs Product Portfolio
-
Table Aurobindo Company Details
-
Table Aurobindo Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aurobindo Generic Drugs Main Business and Markets Served
-
Table Aurobindo Generic Drugs Product Portfolio
-
Table Pfizer (Hospira) Company Details
-
Table Pfizer (Hospira) Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer (Hospira) Generic Drugs Main Business and Markets Served
-
Table Pfizer (Hospira) Generic Drugs Product Portfolio
-
Table Teva Company Details
-
Table Teva Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Generic Drugs Main Business and Markets Served
-
Table Teva Generic Drugs Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Generic Drugs Main Business and Markets Served
-
Table Sanofi Generic Drugs Product Portfolio
-
Table Stada Arzneimittel Company Details
-
Table Stada Arzneimittel Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Stada Arzneimittel Generic Drugs Main Business and Markets Served
-
Table Stada Arzneimittel Generic Drugs Product Portfolio
-
Table Nichi-Iko Pharmaceutical Company Details
-
Table Nichi-Iko Pharmaceutical Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nichi-Iko Pharmaceutical Generic Drugs Main Business and Markets Served
-
Table Nichi-Iko Pharmaceutical Generic Drugs Product Portfolio
-
Table Krka Group Company Details
-
Table Krka Group Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Krka Group Generic Drugs Main Business and Markets Served
-
Table Krka Group Generic Drugs Product Portfolio
-
Table Sun Pharmaceutical Company Details
-
Table Sun Pharmaceutical Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharmaceutical Generic Drugs Main Business and Markets Served
-
Table Sun Pharmaceutical Generic Drugs Product Portfolio
-
Table Lupin Company Details
-
Table Lupin Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lupin Generic Drugs Main Business and Markets Served
-
Table Lupin Generic Drugs Product Portfolio
-
Table Mylan Company Details
-
Table Mylan Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Generic Drugs Main Business and Markets Served
-
Table Mylan Generic Drugs Product Portfolio
-
Table Valeant Company Details
-
Table Valeant Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valeant Generic Drugs Main Business and Markets Served
-
Table Valeant Generic Drugs Product Portfolio
-
Table Apotex Company Details
-
Table Apotex Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Apotex Generic Drugs Main Business and Markets Served
-
Table Apotex Generic Drugs Product Portfolio
-
Table Hikma Company Details
-
Table Hikma Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hikma Generic Drugs Main Business and Markets Served
-
Table Hikma Generic Drugs Product Portfolio
-
Table Novartis - Sandoz Company Details
-
Table Novartis - Sandoz Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis - Sandoz Generic Drugs Main Business and Markets Served
-
Table Novartis - Sandoz Generic Drugs Product Portfolio
-
Table ENDO (Par Pharmaceutical) Company Details
-
Table ENDO (Par Pharmaceutical) Generic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table ENDO (Par Pharmaceutical) Generic Drugs Main Business and Markets Served
-
Table ENDO (Par Pharmaceutical) Generic Drugs Product Portfolio
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injectables Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dermal/Topical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inhalers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Generic Drugs Consumption Forecast by Country (2022-2028)
-
Table North America Generic Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Generic Drugs Consumption Forecast by Country (2022-2028)
-
Figure Germany Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Generic Drugs Consumption Forecast by Country (2022-2028)
-
Figure China Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Generic Drugs Consumption Forecast by Country (2022-2028)
-
Figure Brazil Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Generic Drugs Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Generic Drugs Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Generic Drugs Consumption Forecast by Country (2022-2028)
-
Figure Australia Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
